Acto, the Canada-based developer of a medical product engagement platform, completed an $11.5m series A round yesterday backed by enterprise software provider Salesforce through corporate venturing subsidiary Salesforce Ventures.
Growth equity firm Resolve Growth Partners led the round, which also featured venture capital firm Panache Ventures.
Founded in 2014, Acto has built a mobile-based platform that helps pharmaceutical field representatives interact with doctors and patients. It also allows doctors, nurses and patients to access information on drugs and medical devices.
Parth Khanna, Acto’s co-founder and CEO, said: “Our series A funding will help us advance our vision of building the world’s best omnichannel education and engagement ecosystem for life sciences.
“Working closely with our agency and technology partners, we will not only continue to enhance Acto’s field and [healthcare professional]-facing capabilities, but also accelerate the creation of the largest commercial learning and development portfolio for life sciences and pioneer into patient education.”
The company had previously raised $1.8m in seed funding from Panache Ventures, Accelerator Fund, Extreme Venture Partners, Innovation Grade Ventures, Good News Ventures, Maple Leaf Angels and Cogito Capital in 2018.
